Nội dung

Deng et al. BMC Pulmonary Medicine (2016) 16:166 DOI 10.1186/s12890-016-0328-8 TECHNICAL ADVANCE Open Access Small lung lesions invisible under fluoroscopy are located accurately by three-dimensional localization technique on chest wall surface and performed bronchoscopy procedures to increase diagnostic yields Chaosheng Deng1*, Xiaoming Cao2, Dawen Wu1, Haibo Ding1, Ruixiong You3, Qunlin Chen3, Linying Chen4, Xin Zhang1, Qiaoxian Zhang1 and Yongquan Wu2 Abstract Background: Nowadays, small peripheral pulmonary lesions (PPLs) are frequently detected and the prognosis of lung cancer depends on the early diagnosis. Because of the high fee and requiring specialized training, many advanced techniques are not available in many developing countries and rural districts. Methods: Three sets of opaque soft copper wires visible under the fluoroscopy (Flu) in the Flu-flexible bronchoscopy (FB) group (n = 24), which determined the three planes of the lesion, were respectively placed firmly on the surface of the chest wall with adhesive tape on the chest wall. The FB tip was advanced into the bronchus toward the crosspoint of the three perpendicular planes under Flu with careful rotation of a C-arm unit. Then the specimen were harvested focusing around the crosspoint for pathologic diagnosis. The rapid on-site evaluation (ROSE) procedure was also performed. The average Flu time during FB procedures were recorded and diagnostic accuracy rates in the Flu-FB group were compared with the other group guided by radial endobronchial ultrasound (R-EBUS) (n = 23). Results: The location of the core point of the lesion, whether it was visible or not under the fluoroscopy could be recognized by three-dimensional localization technique. The accuracy rates of diagnostic yields were 62.5% in the Flu-FB group, and was similar as 65.2% in the R-EBUS group (P > 0.05). However, in the Flu-FB group, there was a decreasing tendency on accurate diagnosis rates of lower lobe (LL) lesions when comparing with non-LL lesions (3/8 = 37.5% vs 12/16 = 75%, P = 0.091) while in the R-EBUS group it was similar (9/12 = 75% vs 6/11 = 54.6%, P = 0.278). In the Flu-FB group, fluoroscopy time was negatively correlated with the lesion length (r = −0.613, P = 0.001), however, there was no significant difference between the lesions invisible or not (5.83 ± 1.45 min vs 7.67 ± 2.02 min, P = 0.116) under the fluoroscopy, as well as no significant difference among SPN, mGGO and GGO (6.12 ± 2.05 min, 7.25 ± 1.33 min and 7.80 ± 2.02 min, P > 0.05). (Continued on next page) * Correspondence: jasonsci7333@163.com 1 Division of Respiratory and Critical Care Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China Full list of author information is available at the end of the article © The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Deng et al. BMC Pulmonary Medicine (2016) 16:166 Page 2 of 13 (Continued from previous page) Conclusions: Small PPL whether it is visible or not under fluoroscopy can be located accurately by our threedimensional localization technique on chest wall surface and performed bronchoscopy procedures to increase diagnostic yields. It is more convenient, economical and reliable with the similar diagnostic yields than R-EBUS guided method. Trial registration: Current Controlled Trials ChiCTR-DDD-16009715. The date of registration: 3rd Nov, 2016. Retrospectively registered. Keywords: Small peripheral pulmonary lesions (PPLs), Invisible under fluoroscopy, Three-dimensional localization technique, Opaque soft copper wires, Bronchoscopy, Diagnostic yields, Radial endobronchial ultrasound (R-EBUS), Rapid on-site evaluation (ROSE) Introduction Nowadays, with the application of high-resolution computed tomography (CT) imaging techniques to lung cancer screening, small solitary pulmonary nodule (SPN) or ground-glass opacity (GGO) lesions in the lung are frequently detected [1, 2]. For this article, the small peripheral pulmonary lesions (PPLs) are defined as lesions less than 3 cm in length, including the SPN, GGO or mixed GGO (mGGO) and being surrounded by the lung parenchyma without evidence of endobronchial abnormalities. The differential diagnosis of PPN is broad, ranging from benign tumors, edema, infectious lesions to lung cancer and other malignant conditions [3]. Lung cancer is the most common cause of cancer death for both men and women with a 5-year global survival rate in patients in the early stages of the disease of 38–67% and in later stages of 1–8% [4]. Thus, the prognosis of lung cancer depends on the early diagnosis of these lesions. When biopsy is recommended, CT-guided transthoracic fineneedle aspiration (TTNA) or biopsy is currently preferred because it has a diagnostic yield of 90%, although perhaps less with smaller lesions [5]. However, TTNA has limitations such as without bronchoalveolar lavage fluid (BALF), brushing, and with respect to the puncture site, seeding along the needle biopsy tract with malignant cells which are potentially serious, with a risk from 0.06 to 1%, as well as a high risk of complications such as a pneumothorax median 25% (range 4–60%), among which 4% (range 0.2–8%) for pneumothorax requiring chest tube and the median risk of hemorrhage is 12% (range 2–66%), and may be higher in the diffuse lung disease patients with bulla under pleura and those with smaller nodules or nodules deep in the lung parenchyma [6, 7]. Another more complex process video-assisted thoracoscopic surgery (VATS), even CT assisted VATS [8] is also an alternative method to obtain the tissue samples especially for some small PPNs. However, sometimes the techniques need an additional tool such as Oarm CT or some preoperative marking procedures to identify the location of the small lesions [9, 10]. For example, VATS involves hook-wire technique, endoscopic ultrasonography, barium marking through bronchoscopy, and percutaneous injections of dyes, colored collagen, lipiodol, agar, and barium, et al. [7]. These methods may also result in some complications mentioned above, which led to its prohibition in Japan [11]. The diagnostic yields of another diagnostic method, flexible bronchoscopy, for PPLs <2 cm in the published reports have varied from 5 to 28% [12]. Therefore, several guidedbronchoscopy technologies have been developed to improve the yields of transbronchial biopsy for PPLs diagnosis, such as real-time MSCT fluoroscopic guidance with higher radiation doses to the patient and operators [13], ultrathin bronchoscope, electromagnetic navigation bronchoscopy (ENB), virtual bronchoscopy (VB), REBUS with guide sheath (GS), and lung point [5, 14]. All these methods have improved the diagnostic yields, for example, the overall diagnostic yield of EBUS-GS-guided transbronchial biopsy (TBB) may be 65.0% when the location of the lesion can be confirmed by EBUS [9]. However, in many patients, the location of target lesion is invisible under the x-ray fluoroscopy and yet can not always be identified so precisely by these guidedbronchoscopy technologies and consequentially affect the diagnostic yields. On the other hand, because of the high fee of guided-bronchoscopy equipments and requiring specialized training doctors, the advanced techniques mentioned above are not always available for the hospitals in many developing countries and rural districts. Therefore, we are studying for a more convenient, economical and reliable method for accurately locating the small PPLs, then perform the bronchoscopy procedures to improve the diagnostic yields. And we also perform R-EBUS with GS for comparison. Materials and methods About the protocol The protocol was approved by the University Ethics Committee and the Institutional Review Board of the First Affiliated Hospital of Fujian Medical University and the First Hospital of Longyan City in Fujian Province. Written informed consents prior to performing the Deng et al. BMC Pulmonary Medicine (2016) 16:166 procedure were obtained from all the enrolled patients with the indications as follows: PPNs less than 30 mm in diameter size. The patients with the contraindications for the flexible bronchoscopy were excluded. All patients were followed-up until achievements of definitive diagnosis. Groups Patients from the two hospitals from June 2012 to December 2015 were divided into 3 groups. All patients underwent chest CT scanning using a multidetector CT scanner (Aquilion; Toshiba; Tokyo, Japan) prior to bronchoscopy, in order to locate the lung lesions at full inspiration. Images were reconstructed from helical CT data by one radiologist and transferred to a work site. Our new technique was performed on 24 lesions in 24 patients, we also named as fluoroscopy group, who were classified into 2 groups: group1 (n = 12) and group2 (n = 12) according to the lesion visible or not under fluoroscopy. The lesion visible or not was confirmed by two radiologists. Visible lesion means the lesion can be recognized under fluoroscopy by the both radiologists and invisible lesion means the lesion can not be recognized under fluoroscopy by the both radiologists. However, if the lesion can not be recognized by one, then should be confirmed invisible by the third radiologist. The group 3 was performed EBUS-GS, namely Radial EBUSGS group. Characteristics of patients Among group 1 and 2, each lung lobe (including left lingular) had lesion for confirming to locate accurately the small PPNs. There were 12 patients with lesion visible under fluoroscopy in the group 1 and also 12 patients with lesion invisible under fluoroscopy in the group 2. There were 23 patients in the group 3. The characteristics of three groups were shown at Table 1. Bronchoscopy procedures Bronchoscope was advanced to segment where the lesion located Local anesthesia of the upper respiratory tract was achieved using 2% lidocaine. Continuous pulse oximetry was performed during FB, and blood pressure was measured every 5 min. Oxygen was administered by a nasal cannula, and the flow was adjusted upward from 2 L/min to maintain the pulse oximetric saturation above 90%. After the FB (BF-1T260, Olympus, Tokyo, Japan) was advanced beyond the vocal cords through the nasal route, all segments of the bronchial tree were visualized. Then the FB was advanced to the lesion segment according to the CT scans. FB procedures were performed by well-trained bronchoscopists who had more than 10 years of experience. The average number of FB Page 3 of 13 Table 1 Characteristics of three groups Characteristics Group 1 (n = 12) Group 2 (n = 12) Group 3 (n = 23) Age (years) 61 ± 18 58 ± 16 60 ± 15 Female 7 6 9 Male 5 6 14 Sex (cases) Lesion size (mm) Length 25.25 ± 3.05 13.00 ± 6.00 20.50 ± 5.00 Width 14.42 ± 4.81 9.42 ± 3.61 15.00 ± 4.30 Height 16.42 ± 2.31 7.33 ± 2.78 13.00 ± 6.50 Location and cases of each lobe Right (left) upper lobe 2 2 6 Right middle (left lingular) lobe 2 2 5 Right (left) lower lobe 2 2 12 GGO 0 5 5 mGGO 4 2 6 SPNs 8 5 12 CT findings (Types and Cases) Group 1: Patients with lung lesion visible under fluoroscopy; Group 2: Patients with lung lesion invisible under fluoroscopy; Group 3: Patients performed EBUS-GS procedures performed per year by the bronchoscopist was 200 or greater. Visible lesion under fluoroscopy For the patients with PPN visible under fluoroscopy, fluoroscopy-guided bronchoscopy was performed. Lesions were located accurately by our techniques and performed bronchoscopy procedures Determing core point L of lesion according to crosspoint of three dimensions of lesion All chest CT scans of the enrolled patients were reviewed to detect the longest diameter of three dimensions: length, width and height of the lesion and the characteristics of the all lesions were carefully analyzed. The CT scans mainly aiming at the lesion were reconstructed again with slices of 1 mm under a deep inspiratory breathhold. The bronchi leading to the lesion were also recorded. A core point of the lesion which we named as point L could be determined according to the crosspoint of the longest diameter of three dimensions, that is length, width and height of the lesion, on CT scans (Fig. 1a and b). Especially, if the branches of bronchi leading into the lesion could be recognized, the end point of the bronchi inside the lesion was determined as point L and also was recorded. Point L could be reflected by crosspoint determined by three planes lines on surface of chest wall According to the mathematical principle: Three Perpendicular Planes Intersect at ONE Point, this Point can be Deng et al. BMC Pulmonary Medicine (2016) 16:166 Page 4 of 13 Fig. 1 A core point of the lesion which we named as point L could be determined according to the crosspoint of the longest diameter of three dimensions, that is length, width and height of the lesion, on CT scans (shown by a and b). Opaque soft copper wires were respectively placed firmly on the surface of the chest wall with adhesive tape (shown by c, d and e). Under the fluoroscopy, with the careful rotation of the C-arm machine, the crosspoint L’ of the three perpendicular planes determined by the three sets copper wires aa’, bb’ and hemicycle line c (shown by a and b with bright pots and lines, and by f with dark lines) on the surface of chest wall could reflect and fit accurately with the Point L of the lung lesion (shown by f) reflected onto the surface of the chest wall by the three perpendicular planes lines, that is Sagittal Plane A determined by Line a and Line a’, Coronal Plane B determined by Line b and Line b’ and Horizontal Plane C determined Hemicycle (or Whole Cycle) Line c (Fig. 1a and b). According to the CT parameters scanning the lesion, these three perpendicular planes lines can be marked on the surface of the patients’ chest wall (Clearly shown in Model Fig. 2). Opaque soft wires, such as copper wires which were visible under the fluoroscopy, were respectively placed firmly on the surface of the chest wall with adhesive tape according to the marks (Fig. 1c, d, e). Therefore, although the lung lesion can not be recognized under the fluoroscopy, the another crosspoint we named as L’ of the three perpendicular planes determined by the three sets of copper wires aa’, bb’ and hemicycle line c on the surface of chest wall could reflect and fit accurately with the Point L of the lung lesion (Fig. 1f). Detecting accurately core point L of the lesion under fluoroscopy Fluoroscopic guidance was provided by a multipurpose C-arm type diagnostic unit (Allura Xper FD20; Philipps Company; Amsterdam, the Netherlands). With the careful rotation of a C-arm unit, we can see the wires a and a’ overlapped together like one wire named as Line A, and intersected with hemicycle c toward the x-ray anteroposterior direction, which meaned that Plane A intersected with Plane C at Line A. Then, going on rotating the C-arm unit, we can also see the wires b and b’ overlapped together like one wire named as Line B, and intersected with hemicycle c toward the x-ray horizontal direction, which meaned that Plane B intersected with Plane C at Line B. As mentioned above, the crosspoint L’ was also the crosspoint of Line A and Line B. Therefore, we should advance the bronchoscope tip into the bronchus toward the crosspoint of Line A and Line B, which reflected the core point L of the lesion under the fluoroscopic guidance. Harvesting specimen focusing around the point L of the lung lesion The brush or forceps exserting from the bronchoscopy reached the crosspoint L’ under the fluoroscopy. The specimen were harvested focusing around Deng et al. BMC Pulmonary Medicine (2016) 16:166 Page 5 of 13 Fig. 2 (model): According to the CT parameters scanning the lesion, the three perpendicular lines: Line a and a’ which determined Sagittal Plane a, Line b and b’ which determined Coronal Plane b, and Hemicycle Line c which determined Horizontal Plane c can be marked on the surface of the chest wall the point L of the lesion through the brushing, forceps biopsy, and BALF. ROSE The rapid on-site evaluation (ROSE) procedure was performed by a cytotechnologist after staining the smears from the tissue obtained during the bronchoscopy, enabling immediate cytopathologic evaluation and feedback regarding specimen adequacy and potential diagnosis. At least 2 smears were prepared, one stained immediately with a rapid stain (Diff-Quik, Baxter Diagnostics, Inc) and the other fixed in alcohol for Papanicolaou (PAP) staining later. Cytologic slides were then sent to the pathologist for immediate interpretation of whether the sample was negative (no malignant cells) or positive (definitive cytopathologic evidence of malignancy) [15]. The remaining specimen was placed in 10% formaldehyde for routine histologic examination and diagnosis. Brief case report involving our techniques A 75-year-old female with a 5-months’ history of recurrent hemoptysis was admitted to the First Affiliated Hospital of Fujian Medical University. The lung CT showed an irregular shape nodule with 2.0 cm*2.0 cm*1.5 cm size in the left posterior basal segment lobe (Fig. 3b, c). As the principles and techniques mentioned above, the core point of the lesion was determined. Then three sets of metal wires were placed on the surface of the patient’s chest wall. Although the lesion located behind the heart and was hard to be recognized under the fluoroscopy, the core point of the lesion was detected with the help of our methods of locating lesion (Fig. 3a, d). Subsequently, bronchoscopy procedures under the fluoroscopy were done to harvest the specimen focusing around the core point of the lesion (Fig. 3e, f ). The pathology from specimen showed adenocarcinoma in situ with immunohistochemisty: TTF-1, CK7, CK19, Napsina(+); PR, CEA(focal+); Tg, Villion, CR, CK5/6, CDX-2, CA125, ER, GCDFP-15, CK20, CA199(−), KI-67(+, 1%) (Fig. 3g). EBUS procedures In the group 3 (patients performed EBUS-GS), equipped with endoscopic ultrasound system (EU-M30S, Olympus, Tokyo, Japan), a 20 MHz radial small-diameter probe (UM-S20–20R Olympus) with guide sheath was inserted through the working channel of the bronchoscope. Once Deng et al. BMC Pulmonary Medicine (2016) 16:166 Page 6 of 13 Fig. 3 The lung CT showed an irregular shape nodule with 2.0 cm*2.0 cm*1.5 cm size in the left posterior basal segment lobe (b, c). Although the lesion located behind the heart and was hard to be recognized under the fluoroscopy, the core point of the lesion was detected with the help of our methods of locating lesion (a, d, shown within the white circle). Bronchoscopy procedures under the fluoroscopy were performed to harvest the specimen focusing around the core point of the lung lesion (d, e, shown within the white circle). The pathology from the specimen showed adenocarcinoma (f: ROSE, g: Histology) the precise location of the lesion was identified by EBUS, the probe was withdrawn, leaving the GS in place. Subsequently, the specimen were harvested through the brushing, forceps biopsy, and BALF for ROSE and pathologic diagnosis as other groups. Statistical analysis Data were presented as mean ± standard deviation or number (percent) as appropriate. Statistical analysis was performed using χ2 test or Fisher’s exact test and t-test in SPSS statistical software (SPSS version 15; SPSS; Chicago, IL). A two-sided p value of less than 0.05 indicated statistical significance. Results Results of patients performed bronchoscopy under fluoroscopy The location of the core point L of the lesion had been determined in the chest CT scans. The point L whether it was visible or invisible under the fluoroscopy could be recognized by the crosspoint L’ of the three perpendicular planes determined by the three sets copper wires aa’, bb’ and hemicycle line c on the surface of chest wall. The results of the patients performed bronchoscopy under fluoroscopy were showed in Table 2. Visible lesion under fluoroscopy Fluoroscopy-guided FB was advanced into the bronchus under fluoroscopic guidance according to the lesion location. The brushing, forceps biopsy and BALF focusing on the lesion were performed in these patients (Fig. 4). Results of patients performed bronchoscopy with R-EBUS-GS A total of 23 consecutive patients were included in the study, with 9 female and 14 male. The detail characteristics of this group were shown in group 3 in Table 1. The mean age was 60 ± 15 years (range, 47 to 77 years). The average lesion size in length was 20.50 ± 5.00 mm (range, 10 to 30 mm). Lesion was detected by the R-EBUSGS through FB according to its location (Fig. 5). The accuracy rates of diagnostic yields were 65.2% (15 in 23 cases). ROSE results The cancer cells in the ROSE slides may show as:closter, masslike and overlapped, scattered (Fig. 6). Scattered cancer cells in the slides were prone to be ignored. According to whether the biopsy was successful and adequate diagnostic material was harvested from initial specimens, further specimens collection during bronchoscopy (e.g. brushing, biopsy) will be performed or adjusted the biopsy sites [16]. Accuracy rates of diagnostic cases guided by fluoroscopy guided FB or R-EBUS The accuracy rates of diagnostic yields were 66.7% in the group 1, 58.3% in the group 2, with average 62.5% in these two groups (both were included in the fluoroscopy group), and was similar as 65.2% in the group 3 (REBUS-GS group) (P > 0.05). Accurate diagnosis rates were similar among Flu-FB group and EBUS group (15 in 24 patients vs 15 in 23 patients, P = 0.846). In the FluFB group, there were no significant difference among different CT scan findings (P = 0.503) and whether the Deng et al. BMC Pulmonary Medicine (2016) 16:166 Page 7 of 13 Table 2 Results of patients performed bronchoscopy under fluoroscopy were shown N Location CT finding Size (mm) Distance to Visible or not Histology results from pleura (mm) bronchoscopy Final diagnosis 1 RUL Adenocarcinoma 2 RLL SPN 12*10*11 10 Invisible Negative Adenocarcinoma 9.0 3 LM(L)L mGGO 18*15*10 8 Invisible Inflammation Inflammation 9.5 4 RLL SPN 25*15*14 18 Visible Inflammation? Adenocarcinoma 5 RML GGO 3*4*3 0 Invisible Negative Inflammation 6 LUL SPN 26*18*16 10 Visible Caseous necrosis Caseous necrosis 5.5 7 LUL SPN 25*11*15 5 Visible Carcinoma cells Adenocarcinoma 6.5 8 LLL SPN 9*8*5 10 Invisible Negative AAH 10.0 9 LUL GGO 4*3*3 15 Invisible Negative Inflammation 10.0 mGGO 30*15*15 15 Visible Adenocarcinoma Fluoroscopy time (min) 7.5 7.0 10.0 10 RML SPN 25*16*17 22 Visible Atypical cells AAH 4.5 11 LULΔ SPN 10*10*9 15 Invisible Squamous cell carcinoma Squamous cell carcinoma 8.0 12 LLL SPN 20*20*15 0 Visible Carcinoma cells Adenocarcinoma 7.5 13 RML mGGO 22*8*16 10 Visible Negative Adenocarcinoma 6.5 14 RUL SPN 20*8*6 20 Invisible Squamous cell carcinoma Squamous cell carcinoma 5.0 15 RUL mGGO 25*12*16 15 Visible Negative Caseous necrosis 5.5 Small cell carcinoma 16 RML GGO 11*13*7 20 Invisible Carcinomacells 17 LM(L)L mGGO 30*11*20 0 Visible Poorly differentiated carcinoma Poorly differentiated carcinoma 6.5 18 RUL SPN 18*8*10 30 Invisible Carcinoma cells Squamous cell carcinoma 4.5 19 RLL SPN 25*15*22 28 Visible Small cell carcinoma Small cell carcinoma 4.0 20 RLL GGO 19*14*6 30 Invisible Negative Squamous cell carcinoma 6.0 21 LLL SPN 22*10*16 30 Visible Negative Inflammation 3.5 22 LM(L)L SPN 25*12*15 32 Visible Adenocarcinoma Adenocarcinoma 4.5 23 LLL* mGGO 20*10*8 35 Invisible Carcinoma cells Adenocarcinoma 7.0 24 LM(L)L GGO 12*10*10 25 Invisible Carcinoma cells Large cell carcinoma 6.5 7.5 N Number of cases, Visible:lesion can be recognized under fluoroscopy. Invisible:lesion can not be recognized under fluoroscopy. Visible or not: Visible or not under fluoroscopy. Histology results from bronchoscopy include brushing, BALF and biopsies under fluoroscopy. Final diagnosis: histology pathological diagnosis or diagnosis by following up. RUL Right Upper Lobe, RML Right Middle Lobe, RLL Right Lower Lobe, LUL Left Upper Lobe, LM(L)L Left Lingular Lobe, LLL Left Lower Lobe, SPN Solitary Pulmonary Nodules, (m)GGO (mix) Ground Glass Opacity, AAH Atypical Adenomatous Hyperplasia. *:minor hemorrhage at the biopsy site; Δ:pneumothorax not requiring chest tube lesion visible or not under the fluoroscopy (P = 0.50). However, in the Flu-FB group, there was a decreasing tendency on accurate diagnosis rates of LL lesions when comparing with non-LL lesions (3/8 = 37.5% vs 12/16 = 75%, P = 0.091) while in the EBUS group it was similar (9/12 = 75% vs 6/11 = 54.6%, P = 0.278). And in the EBUS group, there was a significant difference among different CT scan findings (P = 0.044) with SPN vs GGO (P = 0.028) and whether the lesion detectable or not by EBUS (P = 0.008) (Table 3). ((6.75 ± 2.24) min vs (6.75 ± 1.88) min, P > 0.05). The length of the visible lesion is much larger than the invisible lesion (25.00 ± 2.92 mm vs 13.00 ± 6.00 mm, F = 8.844, P = 0.007). Fluoroscopy time was negatively correlated with the lesion length (r = −0.613, P = 0.001). However, about fluoroscopy time, there was no significant difference between visible lesion and the invisible lesion (5.83 ± 1.45 min vs 7.67 ± 2.02 min, P = 0.116), as well as no significant difference among SPN, mGGO and GGO (6.12 ± 2.05 min, 7.25 ± 1.33 min and 7.80 ± 2.02 min, P > 0.05). Average fluoroscopy time during bronchoscope procedures Complications In the fluoroscopy group (Flu-FB group), the average fluoroscopy time was (6.75 ± 1.96) min. There were no significant difference of the fluoroscopy time in lower lobe patients compared with the not lower lobes patients There was 1 patient with the complication of minor hemorrhage and 1 patient with pheumothorax not requiring chest tube in group 2. No complication was found in other groups. Deng et al. BMC Pulmonary Medicine (2016) 16:166 Page 8 of 13 Fig. 4 Bronchoscopy procedures focusing on the visible lesion were performed under fluoroscopic guidance according to the lesion location. a, Lesion was showed in Right Upper Lobe within circle. b, Lesion was showed in Left Upper Lobe within circle. c, Lesion was showed in Right Lower Lobe within circle. d, Lesion was showed in Left lower Lobe within circle Discussion All of lung lesions shown by chest CT scans can be successfully localized by our techniques Lung cancer is currently the leading cause of cancer deaths worldwide. The mortality rates have remained high because of the difficulty in detecting early stage of this disease. Fortunately, with the wide application of HRCT, PPLs are frequently detected which made early diagnosis become possible. However, using CT characteristics alone to determine the lesions as benignity, premalignancy or malignancy is often difficult [17]. The tissue samples of the PPNs can be harvested by the FB. The location of the lesion should be determined before harvesting the samples, thus can improve the diagnostic yield. The lung lesion location is estimated by chest radiograph (CXR) or CT of the chest. It is a challenge to determine the location of the small lesion, especially which is invisible under the fluoroscopy. However, whether the lung lesion is visible or not under the fluoroscopy. The core point of the lesion detected by CT scans can be reflected by the crosspoint of three planes determined by the three sets of opaque soft wires placed Fig. 5 Lesions were detected by the R-EBUS-GS through bronchoscopy according to their locations in different lobes (Right lower lobe shown in A and a; Right upper lobe shown in B and b; Left lower lobe shown in C and c; Left lingular lobe shown in D and d) Deng et al. BMC Pulmonary Medicine (2016) 16:166 Page 9 of 13 Fig. 6 The cancer cells in the ROSE slides may show as: closter (shown by a), masslike and overlapped (shown by b), scattered (shown by c and d) P = 0.003) [18]. However, the diagnostic yields of FB for peripheral pulmonary lesions <2 cm in published reports have varied from 5 to 28%, because some lesions are invisible through conventional flexible bronchoscopy under fluoroscopy [12]. In our study, although lung lesion is invisible under fluoroscopy, we can recognize it by the crosspoint of three perpendicular planes determined by the opaque soft copper wires placed on chest wall surface, therefore, the diagnostic yields have been improved, which is similar as REBUS-GS group. And this location method will not be influenced by the different size, whether the lesion visible or not under the fluoroscopy and CT scan characteristics of the lesion, such as SPN, mGGO or GGO. on the surface of chest wall. According to the mathematical principle: Three Perpendicular Planes Intersect at ONE Point, the lesion can be located accurately by our techniques. Then, under the fluoroscopy, the bronchoscopy procedures can be performed aiming at the crosspoint of the three perpendicular planes and the specimen can be harvested by focusing around the point, which is also the core point of the lung lesion. This technique does not make use of sophisticated equipments, and it is easy to be understood and mastered. Performing bronchoscopy by our three-dimensional localization technique Accuracy rates of diagnosis by bronchoscopy whether lesion is visible or not under fluoroscopy are similar For non-endobronchial peripheral lung lesion, if the lesion is visible under fluoroscopy, the brush and biopsy forceps of the bronchoscopy can be advanced into the bronchus under fluoroscopic guidance according to the lesion location, as been successfully performed in our study. According to Rittirak et al. study, the overall diagnostic yield of Flu-TBLB group may be statistically significantly higher than NFlu-TBLB group (43.8 vs. 32.9%; Accuracy rates of diagnosis by bronchoscopy of non-lower lobe lesion are higher than lower lobe lesion However, due to the respiratory motion, mainly caused by the diaphragm motion, the lung lesion may be mislocalized [19]. Movement of the lung occurs with respiratory variation during bronchoscopy, and the location of pulmonary nodule during procedures may differ significantly from its location on the initial planning, especially Table 3 Accuracy rates of diagnostic cases guided by fluoroscopy guided FB or R-EBUS Methods Cases Items Flu-FB EBUS Lesion location UL ML CT scan findings LL SPN mGGO Lesion under fluoroscopy or EBUS GGO Visible Invisible Cases enrolled 8 8 8 13 6 5 12 12 Accurate diagnosis 6 6 3 9 4 2 8 7 Cases enrolled 6 5 12 12 6 5 19 4 Accurate diagnosis 3 3 9 10 4 1 15 0 UL Upper lobe, ML Middle lobe, LL Lower lobe. Lesion under fluoroscopy or EBUS Deng et al. BMC Pulmonary Medicine (2016) 16:166 to the lower lobe, which moved significantly more than upper lobe lesion. In the Flu-FB group of our study, a decreasing tendency has been observed on accurate diagnosis rates of LL lesions when comparing with nonLL lesions, while in the EBUS group it was similar. Actually, one of the main challenges for us is hard to find the exact position to perform a biopsy for the lesion located in the lower lobe when respiratory motion. According to the other studies, this movement during bronchoscopy may even significantly affect the diagnostic yield of electromagnetic navigation bronchoscopy procedures [20]. The lesion size and distance from the pleura doesn’t significantly impact the movement. Holding a deep breath may manage the respiratory motion problem, but the duration of bronchoscopy procedures which involve BALF, biopsy, brushing et al., may take some longer time. The navigation system with the proposed respiratory motion compensation method and EBUS allow for real time guidance during bronchoscopic interventions, and thus could increase the diagnostic yield [21]. Therefore, combing with other diagnostic techniques may improve diagnostic yields. Diagnostic yield about R-EBUS The technique of R-EBUS with a GS has definitely its place in the diagnostic work-up of PPLs, especially for the lesions that can be visualized by EBUS. The diagnostic yield has fluctuated from 53% up to 77% [22], which can be increased by ensuring that TBB is performed at the correct location as identified by the EBUS. Tay et al. performed a retrospective analysis of 196 consecutive patients who underwent investigation with R-EBUS [23]. They found that a definitive diagnosis was established for 109 PPL (56%) using radial EBUS. Visualized lesion by EBUS probe had a higher diagnostic yield (65%) than EBUS-invisible lesions (20%; P = 0.0001) and in multivariate analysis, lesion size, malignancy status and distance from hilum to lesion were significant predictors of EBUS visualization yield. In our study, lesions performed R-EBUS were visualized by EBUS probe and there were same diagnostic yields as Tay et al’s study. On the other hand, different CT scan findings have been associated with different diagnostic yields bronchoscopy guided by R-EBUS-GS, especially high with SPN lesion and low with GGO lesion. However, the overall diagnostic yields by R-EBUS-GS were similar with that by our threedimensional localization technique according to our study. What we are concerned about is that the diagnostic yield of EBUS-invisible lesions may be improved according to our three-dimensional localization technique. CT-guided transthoracic fine-needle aspiration TTNA or biopsy is widely used currently for its high diagnostic yields [5]. However, TTNA has a limitation Page 10 of 13 mentioned in the introduction part. Tai et al. has evaluated the frequency and severity of pulmonary hemorrhage after transthoracic needle lung biopsy (TTLB) and assess possible factors associated with pulmonary hemorrhage [24]. Tai et al. has found that the pulmonary hemorrhage occurred in 483 of the 1175 TTLBs (41.1%) but rarely requires intervention and higher-grade hemorrhage was more likely to occur with female sex (P = 0.001), older age (P = 0.003), emphysema (P = 0.004), coaxial technique (P = 0.025), nonsubpleural location (P < 0.001), lesion size of 3 cm or smaller (P < 0.001), and subsolid lesions (P = 0.028). However, to the lower lobe lesion, because of low accuracy rates of diagnosis by our techniques, we recommend to perform CT-guided TTNA or combine with other motheds to improve the diagnostic yield. Role of ROSE As we know, ROSE of tissue obtained by FNA has been first introduced by Washington University investigators in St. Louis, Missouri. Its major advantages have been improvements in health care resource utilization, safety, reduction in the number of sites biopsied, allowing immediate processing and interpretation of the sample in the procedural suite, lowering patient costs, increase of sample adequacy rates and diagnostic yield, decrease xray exposure time during radiologically guided interventional procedures and other potential morbidity related to the biopsy procedure [25–28], which has been reported to have 85 to 93% sensitivity and 100% specificity [29]. ROSE can also aim at molecular profiling (optimal lung cancer genotyping) in patients with advanced lung cancer [30]. Therefore, it is recommended to be performed routinely, especially in patients with a suspected diagnosis of lung cancer [31]. In our study, ROSE has been performed in the 3 groups and the cancer cells were found to be mainly distributed as :1) closter, 2) masslike and overlapped, and 3) scattered. Scattered cancer cells in the slides were prone to be ignored. Therefore, the scattered characteristics of cancer cells should be paid much more attention to. However, the main reason for the scarcity of performing ROSE in other practices is oftenly the lack of on-staff cytopathologists [32]. Fluoroscopy time in our study It takes appropriated procedure time to perform bronchoscope under fluoroscopy. There are a negative correlation between the fluoroscopy time and the lesion length. However, because the lesions can be located accurately by our techniques and performed bronchoscopy procedures, there is no significant difference on fluoroscopy time between visible lesion and the invisible lesion, as well as no significant difference among SPN, mGGO